Healthcare Professionals

Farooq Sheikh is an attending physician at MedStar Washington Hospital Center (MWHC), where he specializes in advanced heart failure and cardiac transplantation. At…

Tibor Kovacsovics, MD

Tibor Kovacsovics is the Medical Director for the Inpatient Service of the Division of Hematology and Hematologic Malignancies, as well as Associate Director of…

Caitlin Costello, MD

Caitlin Costello is an Associate Professor of Medicine at University of California, San Diego Health and board-certified hematologist and medical oncologist who…

Noel R. Dasgupta, MD

Frederick L. Ruberg, MD

Frederick L. Ruberg, MD is an Associate Professor of Medicine and Radiology at Boston University (BU) School of Medicine and clinical cardiologist at Boston Medical…

Craig C. Hofmeister, MD, MPH

Craig C. Hofmeister is Associate Professor, Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in internal…

Keith E. Stockerl-Goldstein, MD

Keith E. Stockerl-Goldstein is a Professor of Medicine in Division of Oncology, Section of Bone Marrow Transplant, Washington University School of Medicine. He is…

John M. Sloan, MD

John M. Sloan specializes in hematology-oncology in Boston, Massachusetts, United States. He graduated from Yale University School of Medicine with his medical…

First page
Previous page
…
7
8
9
10
11
12
13
14
15
…
Next page
Last page

Subscribe to

Newsletter

Expert and Community Perspectives on Attruby®

In this special session, Dr. Barry Trachtenberg and members of the ATTR amyloidosis community came together to share medical insights and lived experiences related to Attruby™ (acoramidis). This expert-led discussion explores the clinical data, the patient perspective, and what lies ahead for those considering or currently taking Attruby.